ClinicalTrials.Veeva

Menu

DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron (SideralDose)

C

Cardiochirurgia E.H.

Status and phase

Not yet enrolling
Phase 4

Conditions

Anemia

Treatments

Drug: Sucrosomial Iron

Study type

Interventional

Funder types

Other

Identifiers

NCT07038330
SideralDose

Details and patient eligibility

About

Randomization to different doses of Sucrosomial Iron for one moth after discharge to rehab after heart surgery to assess if more iron grants a faster recovery or not

Full description

Evaluation of the efficacy of short-term sucrosomial iron treatment in patients undergoing cardiac surgery and subsequently transferred to rehabilitation, measured in terms of increase in hemoglobin values and restoration of martial blood parameters, administering doses of 30mg, 60mg and 120mg respectively, after randomization of patients.

Numerical congruity analysis, power sampling, biometric characteristics of internal compatibility between cohorts and outcome analysis with comparison for continuous homoscedastic case-control variables

Drafting of formal statistical analysis, drafting of information synopsis, writing, validation, forwarding to scientific journal and correction until obtaining, where possible, publications of the manuscript relating to the research.

Enrollment

150 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Hb<11; Having had Heart Surgery, Being Discharged to Rehab

Exclusion Criteria:

  • Hb>11.1, hematological primary disesases

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 3 patient groups

30mg
Experimental group
Description:
1 cp (30mg) per day of Sucrosomial Iron
Treatment:
Drug: Sucrosomial Iron
60mg
Experimental group
Description:
2 cp (60mg) per day of Sucrosomial Iron
Treatment:
Drug: Sucrosomial Iron
120mg
Experimental group
Description:
4 cp (120mg) per day of Sucrosomial Iron
Treatment:
Drug: Sucrosomial Iron

Trial contacts and locations

0

Loading...

Central trial contact

Luca P Weltert, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems